PUBLIC PORTAL

MEDICALLY REVIEWED

Singapore’s HSA New Drugs and Indications Approval – Aug 2021

Share on email
Share on print
Share on whatsapp

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of medications that are newly approved or medications with newly approved indication(s). This list can be found on HSA’s website.

August 2021

  • New drugs approved: 1
  • New drug indications approved: 1

New drugs approved

Product name Active ingredient(s) Dosage Form Strength of dosage form Route of Administration Indication(s) Pharmaceutical company Approval Date
Leqvio Inclisiran Pre-Filled Syringe/Pen 284mg/1.5mL Injection Treatment in adults with primary hypercholesterolaemia, as an adjunct to diet Novartis 03 Aug 2021

New drug indications approved

Product name Active ingredient(s) Dosage Form Strength of dosage form Route of Administration Indication(s) Pharmaceutical company Approval Date
Lipiodol Ultra-Fluide Ethyl Esters of Iodised Fatty Acids of Poppy-Seed Oil Ampoule 38% w/w Injection Visualisation, locating and vectoring during transarterial chemoembolisation of intermediate-stage hepatocellular carcinoma in adults. Angeion Medical International 26 Aug 2021

Share via

Share on email
Share on facebook
Share on whatsapp
Share on telegram
Share on twitter
Share on linkedin

Also worth reading